PROactive Clinical Insights

Leverage the gold standard in patient-centric insights throughout the product lifecycle

Reliance on patient insights provides increased value for the development of new treatments. Understanding health-related quality of life (HRQoL) and disease burden from the patient's perspective offers treatment development teams as much knowledge about unmet clinical needs as assessing the efficacy of new treatments.

Data derived from real patient experiences using patient-reported outcome (PRO) measures can fill crucial knowledge gaps in clinical research and commercialization. Discover how PROs have become versatile instruments that enhance decision-making throughout the entire clinical trial.

Patient-Reported Outcomes

Health outcomes reported by patients or study subjects themselves without interpretation by clinicians, caregivers or other observers. Data is captured via self-directed, self-completed questionnaires or surveys that are standardized and validated.

COMPUTER
TABLET
SMARTPHONE
INTERVIEWER SCRIPT
PAPER FORM
DCT COMPATIBLE

Applying PROs across Clinical Trials

Measures like QualityMetric's SF-36v2® and SF-12v2® health surveys can inform decisions in every phase of research. Make the most of gathered insights with QM survey interpretation and linguistic validation services.

Preclinical

Investigating the application of a new drug
Discover More
- Use generic health status PROs to identify unmet clinical need through population-level health surveys using SF-36v2/SF-12v2 and general population norms and disease specific benchmarks
- Unmet clinical needs drive development of new treatments
- ACT – identify uncontrolled disease with current therapies
- HIT-6 – screen for migraine; identify uncontrolled disease with current therapies
- Identification of unmet clinical needs drive
  development of new treatments
Phase I

Determining initial drug safety and dosing
Discover More
- Optimal time to develop PRO/COA measurement strategy for clinical trial programs
- Conduct landscape analysis of available PRO/COA instruments available in therapeutic are under study
- Identify gaps in currently available PRO/COA tools as fit-for-purpose endpoints in clinical trials
- Conduct qualitative/quantitative research to produce necessary evidence to address gaps
- Launch new instrument development initiatives when necessary or modify existing instruments using information from qualitative research
- Select endpoints to guide strategic
  data collection
Phase II

Provide treatment benefits and key stakeholders
Discover More
- Phase II trials can be used to gather information on the reliability, validity and responsiveness of new PRO/COA tools developed for the trial program
- Phase II trials can be used to gather information on the reliability, validity and responsiveness of existing legacy PRO/COA tools that were not developed specifically for the disease being studied in the trial program
- Phase II trials can be used to establish clinically meaningful thresholds of change in the primary efficacy endpoint using PROs as the criterion measure (how much needs to change on the primary efficacy endpoint that results in a clinically meaningful improvement in patient's functional status and well-being)
- Phase II trials can be used to establish clinically meaningful changes in PROs/COAs for the disease being studied in the trial program
- Phase II trials can be used to explore when it is appropriate to elevate a PRO from exploratory to a secondary efficacy endpoint
- Explore potential treatment efficacy
  and tolerability
Phase III

Comparing drug to existing market options
Discover More
- As secondary endpoints, PROs provide important information on the benefits of treatment in terms that matter most to patients
- As exploratory endpoints, PROs can provide important messaging about product benefits that resonate with other stakeholders beyond regulatory, such as payors and consumers
- As an endpoint, PROs can provide important messaging about product benefits in peer reviewed publications, poster and abstracts presented at professional conferences, that assist brand teams positioning of products
- As an endpoint, PROs can provide important messaging about patient benefits that can be incorporated in product labels
- As an exploratory endpoint, PROs can be used to provide evidence to support claims on benefits of treatment observed with primary and secondary efficacy endpoints
- Provide evidence and support compliance
  including, label and marketing claims
Phase IV

Monitoring drug for long-term performance
Discover More
- Use to build real world evidence to support product label claims
- Contribute to comparative effectiveness research
- Examine patient treatment
  experiences over time
Post-Launch

Marketing drug to stakeholders and users
Discover More
- PROs can be used to build brand awareness about treatment benefits beyond clinical outcomes and in terms that matter most to patients/consumers
- Deploy PROs to craft product messaging with real patient experience and analytics
- Develop strong patient-centric
  product messaging

Why Capture Patient Perspectives

QualityMetric's patient-reported outcome (PRO) measures and clinical outcome assessment (COA) services can provide the answers you need to take your product from innovative idea to powerful solution at every phase of your clinical trial. Reach out to us today to learn more about PRO health surveys for your next clinical trial.

BACK

Select the organization that best describes your company:

First Name(Required)

Last Name(Required)

Organization Type(Required)

Organization(Required)

Email Address(Required)

Phone(Required)

Country(Required)

State(Required)

City(Required)

Untitled(Required)

Hidden

Source URL

Thank you for your request.

QualityMetric is reviewing your application and will get back to you shortly with approval to move forward with a license to administer, collect, score, and interpret the data for your project/study.

Next steps:

If you have started administering the survey, please email a copy of the survey being administered to [email protected]. We will QA the form for any changes that may affect the scoring and interpretation of the data collected. (Fees may apply).

If you are applying for a student license, please email a copy of your student ID to [email protected].

Cookie	Duration	Description
AWSALBCORS	7 days	This cookie is managed by Amazon Web Services and is used for load balancing.
CookieConsent	37 years 2 months 12 days 3 hours 15 minutes	This cookie stores the user's consent state for the current domain.
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-functional	1 year	The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Cookie	Duration	Description
__cf_bm	30 minutes	This cookie, set by Cloudflare, is used to support Cloudflare Bot Management.
AWSALB	7 days	AWSALB is an application load balancer cookie set by Amazon Web Services to map the session to the target.

Cookie	Duration	Description
CONSENT	2 years	YouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
cusid	30 minutes	ClickDimensions sets this cookie to establish and continue a user session with the site.
cuvid	2 years	This cookie, set by ClickDimensions, is written to the browser upon the first visit to the site from that web browser.
cuvon	30 minutes	ClickDimensions sets this cookie to store the last time a visitor viewed a page.

Cookie	Duration	Description
VISITOR_INFO1_LIVE	5 months 27 days	A cookie set by YouTube to measure bandwidth that determines whether the user gets the new or old player interface.
YSC	session	YSC cookie is set by Youtube and is used to track the views of embedded videos on Youtube pages.
yt-remote-connected-devices	never	YouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
yt-remote-device-id	never	YouTube sets this cookie to store the video preferences of the user using embedded YouTube video.

PROactive Clinical Insights

Leverage the gold standard in patient-centric insights throughout the product lifecycle

Patient-Reported Outcomes

Applying PROs across Clinical Trials

Preclinical

Phase I

Phase II

Phase III

Phase IV

Post-Launch

Why Capture Patient Perspectives

Select the organization that best describes your company:

Survey License Application

Thank you for your request.